|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.87 CNY | +0.93% |
|
-0.72% | -4.96% |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 607.41 million compared to CNY 374.31 million a year ago. Net income was CNY 194.26 million compared to CNY 111.09 million a year ago.
Basic earnings per share from continuing operations was CNY 1.8 compared to CNY 1.37 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.96% | 924M | |
| +43.36% | 54.64B | |
| -5.31% | 39.92B | |
| +37.52% | 38.82B | |
| +14.75% | 26.86B | |
| -12.56% | 26.22B | |
| -22.45% | 18.78B | |
| +0.04% | 12.16B | |
| +25.12% | 12.21B | |
| +26.04% | 11.94B |
HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD. 
